Skip to content
Zenith Health Care logo

Zenith Health Care

530665 BSE
₹3.22

Close ·

P/E
80.50
View as Markdown
MCP
Close 4 Nov 2026 ₹3.22 −0.64 −16.6% 1Y
Start ₹3.86

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare

Price-based figures at the close · EPS basis: Standalone · TTM

ROCE
0.27%
Debt to Equity
0.00
EPS (TTM)
₹0.04
Book Value
₹1.41
Market Cap
—
P/E (TTM)
80.50
P/B
2.28
ROE
0.13%
Dividend Yield
0.00%
EBITDA
₹30.00 L
52W High
₹4.15
52W Low
₹2.23

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

40 Weak

Data confidence 98/100

Category scores

Quality
27
Poor
Returns, margins, earnings quality 22% weight
Valuation
22
Poor
Cheap vs sector & own history 24% weight
Growth
26
Poor
Sales & profit trajectory 9% weight
Financial Health
69
Strong
Solvency, leverage, coverage 9% weight
Momentum
57
Good
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company is almost debt free.

Weaknesses

5
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -5.20% over past five years.
  • Promoter holding is low: 28.7%
  • Company has a low return on equity of 0.77% over last 3 years.
  • Working capital days have increased from 84.2 days to 122 days

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBearish775
OscillatorsBullish072
Moving AveragesStrong Bearish703

Key readings

RSI (14)
48.25
Neutral
MACD (12,26,9)
0.08
Bullish
SMA (50)
3.21
Bullish
SMA (200)
3.20
Bullish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+11.76%
5Y−5.20%
3Y−7.12%
1Y−7.15%
TTM−9.40%

Net profit

Net profit growth by window
10YTurned to profit
5Y−53.09%
3Y−50.00%
1Y−85.71%
TTMTurned to profit

Operating cash flow

Operating cash flow growth by window
10YTurned negative
5YOutflow narrowed by ₹0.64 Cr
3YOutflow narrowed by ₹0.09 Cr
1YTurned negative
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+5.41 pp
5Y−3.86 pp
3Y−1.47 pp
1Y−2.03 pp
TTM+2.99 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹4.79 Cr
Mar 2018₹9.51 Cr
Mar 2019₹9.83 Cr
Mar 2020₹11.98 Cr
Mar 2021₹13.74 Cr
Mar 2022₹22.36 Cr
Mar 2023₹13.13 Cr
Mar 2024₹14.47 Cr
Mar 2025₹11.33 Cr
Mar 2026₹10.52 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017−₹0.15 Cr
Mar 2018₹0.27 Cr
Mar 2019₹0.14 Cr
Mar 2020₹0.57 Cr
Mar 2021₹0.44 Cr
Mar 2022₹0.31 Cr
Mar 2023₹0.08 Cr
Mar 2024₹0.20 Cr
Mar 2025₹0.07 Cr
Mar 2026₹0.01 Cr

Quarterly Results

₹ Cr
530665 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
4.07
3.49
3.89
3.07
2.57
3.03
2.31
3.43
3.15
2.27
2.48
2.62
3.43
Expenses
3.76
3.36
3.79
3.31
2.45
2.89
2.51
3.41
3.29
2.1
2.2
3.08
3.26
Operating Profit
0.31
0.13
0.1
−0.24
0.12
0.14
−0.2
0.02
−0.14
0.17
0.28
−0.46
0.17
OPM %
7.62%
3.72%
2.57%
−7.82%
4.67%
4.62%
−8.66%
0.58%
−4.44%
7.49%
11.29%
−17.56%
4.96%
Other Income
0
0.04
0.06
0.11
0.08
0.08
0.16
0.11
0.17
0.11
0.04
0.1
0.07
Interest
0
0
0.01
0
0
0
0
0
0
0
0
0
0
Depreciation
0.05
0.06
0.05
0.05
0.04
0.04
0.07
0.08
0.06
0.07
0.07
0.06
0.06
PBT
0.26
0.11
0.1
−0.18
0.16
0.18
−0.11
0.05
−0.03
0.21
0.25
−0.42
0.18
Tax %
0%
0%
0%
38.89%
0%
44.44%
172.73%
−120%
−33.33%
38.1%
8%
−19.05%
22.22%
Net Profit
0.26
0.12
0.1
−0.26
0.16
0.09
−0.29
0.11
−0.02
0.14
0.22
−0.34
0.14
EPS (₹)
0.05
0.02
0.02
−0.05
0.03
0.02
−0.05
0.02
0
0.03
0.04
−0.06
0.03

Profit & Loss

₹ Cr
530665 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
3.64
3.46
4.79
9.51
9.83
11.98
13.74
22.36
13.13
14.47
11.33
10.52
10.8
Expenses
3.68
3.69
4.73
8.95
9.63
11.43
13.38
21.91
13.1
14.23
11.24
10.65
10.64
Operating Profit
−0.04
−0.23
0.06
0.56
0.2
0.55
0.36
0.45
0.03
0.24
0.09
−0.13
0.16
OPM %
−1.1%
−6.65%
1.25%
5.89%
2.03%
4.59%
2.62%
2.01%
0.23%
1.66%
0.79%
−1.24%
1.48%
Other Income
0.05
0.12
0.08
0.13
0.21
0.3
0.46
0.52
0.38
0.26
0.43
0.41
0.32
Interest
0.01
0.01
0.01
0.01
0
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0
Depreciation
0.35
0.35
0.3
0.28
0.25
0.25
0.25
0.36
0.28
0.21
0.23
0.26
0.26
PBT
−0.35
−0.47
−0.17
0.4
0.16
0.59
0.56
0.6
0.12
0.28
0.28
0.01
0.22
Tax %
−31.43%
−36.17%
−11.76%
32.5%
18.75%
3.39%
19.64%
48.33%
33.33%
25%
78.57%
200%
—
Net Profit
−0.24
−0.31
−0.15
0.27
0.14
0.57
0.44
0.31
0.08
0.2
0.07
0.01
0.16
EPS (₹)
−0.04
−0.06
−0.03
0.05
0.03
0.11
0.08
0.06
0.01
0.04
0.01
0
0.04
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
530665 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
5.37
5.37
5.37
5.37
5.37
5.37
5.37
5.37
5.37
5.37
5.37
5.37
Reserves
0.48
0.17
0.02
0.29
0.43
1.03
1.47
1.78
1.86
1.96
2.03
2.05
Borrowings
0
0
0
0
0.02
0
0
0
0
0
0
0
Other Liabilities
0.6
1.04
0.74
1.43
1.14
2.14
1.92
4.52
2.02
2.56
3.48
3.56
Total Liabilities
6.45
6.58
6.13
7.09
6.96
8.54
8.76
11.67
9.25
9.89
10.88
10.98
Fixed Assets
2.17
1.93
1.75
1.81
1.62
1.7
1.8
1.75
1.5
1.4
1.55
1.45
CWIP
0
0
0
0
0
0.17
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0.01
Other Assets
4.28
4.65
4.38
5.28
5.34
6.67
6.96
9.92
7.75
8.49
9.33
9.52
Total Assets
6.45
6.58
6.13
7.09
6.96
8.54
8.76
11.67
9.25
9.89
10.88
10.98

Cash Flow

₹ Cr
530665 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.19
0.23
0.23
0
−0.06
1.95
−1.47
1.32
−0.92
1.74
0.55
−0.83
Investing
−0.14
0.01
−0.12
0
−0.05
−0.5
−0.19
−0.23
−0.03
−1.88
−0.96
0.85
Financing
0
0
0
0
0.02
−0.02
0
0
0
0
−0.01
−0.01
Net Cash Flow
0.05
0.24
0.11
0
−0.09
1.44
−1.65
1.09
−0.95
−0.14
−0.41
0.01
Free Cash Flow
−0.18
0.11
0.11
0
−0.11
1.45
−1.66
1.08
−0.95
1.63
0.16
−0.99
CFO/OP
−475
−100
383
0
−15
356
−372
333
−2,967
796
667
615

Ratios

530665 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
184
133
84.58
54.88
33.79
31.08
44.89
53.05
64.22
57.26
77.96
72.51
Inventory Days
171
297
180
103
126
99.18
145
105
147
86.65
153
220
Days Payable
86.27
178
78.95
82.53
47.61
84.31
71.22
37.63
51.11
38.08
92.93
115
Cash Conversion Cycle
268
253
186
75.01
112
45.95
119
120
161
106
138
177
Working Capital Days
247
209
136
82.13
96.17
48.14
98.02
50.93
117
60.54
69.91
122
ROCE %
−5.71%
−8.08%
−2.93%
7.42%
2.79%
9.82%
8.61%
8.72%
1.81%
3.98%
3.12%
0.27%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Zenith Health Care insights

63 extracted metrics across FY11–FY27.

Shareholding Pattern

As of Sep 2026

  • Public 63.87%
  • Promoters 28.74%
  • Others 7.00%
  • DIIs 0.39%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Zenith Health Care

What does Zenith Health Care Ltd do?
Incorporated in 1993, Zenith Health care Ltd is engaged in manufacturing and trading of pharma products
Where is Zenith Health Care Ltd (ZENITHHE) listed?
Zenith Health Care Ltd trades under code 530665 on the BSE.
Which sector does Zenith Health Care Ltd belong to?
Zenith Health Care Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the PE ratio of Zenith Health Care Ltd?
Zenith Health Care Ltd trades at a PE ratio of 80.50 as of 4 Nov 2026, on earnings per share of ₹0.04, against a book value of ₹1.41 per share.
What is the 52-week high and low of Zenith Health Care Ltd?
Over the last 52 weeks Zenith Health Care Ltd has traded between ₹2.23 and ₹4.15 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Zenith Health Care Ltd?
Zenith Health Care Ltd reported a return on equity of 0.13%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 1993, Zenith Health care Ltd is engaged in manufacturing and trading of pharma products

Face Value ₹1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/530665.md for Zenith Health Care Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More